Mesoblast Ltd (MESO)

3.580
0.000(0.00%)
After Hours
3.580
0.000(0.00%)
- Real-time Data
  • Volume:
    52,412
  • Day's Range:
    3.530 - 3.620
  • 52 wk Range:
    3.230 - 8.850

MESO Overview

Prev. Close
3.58
Day's Range
3.53-3.62
Revenue
9.89M
Open
3.53
52 wk Range
3.23-8.85
EPS
-0.76
Volume
52,412
Market Cap
459.37M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
74,698
P/E Ratio
-
Beta
3.05
1-Year Change
-50%
Shares Outstanding
649,911,648
Next Earnings Date
Aug 30, 2022
What is your sentiment on Mesoblast?
or
Market is currently closed. Voting is open during market hours.

Mesoblast Ltd News

  • Mesoblast Earnings, Revenue Miss in Q3
    • ByInvesting.com-

    Investing.com - Mesoblast (NASDAQ:MESO) reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast...

  • Mesoblast Earnings, Revenue Beat in Q2
    • ByInvesting.com-

    Investing.com - Mesoblast (NASDAQ:MESO) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Mesoblast announced...

  • Mesoblast Earnings, Revenue Miss in Q1
    • ByInvesting.com-

    Investing.com - Mesoblast (NASDAQ:MESO) reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast...

Mesoblast Ltd Analysis

Mesoblast Ltd Company Profile

Mesoblast Ltd Company Profile

Employees
83

Mesoblast Limited is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company is using its mesenchymal lineage cell technology platform to develop and commercialize allogeneic cellular medicines to treat complex inflammatory diseases. Its product candidate includes Remestemcel-L ((RYONCIL) for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), Rexlemestrocel-L (REVASCOR) for the advanced chronic heart failure (CHF) and MPC-06-ID for the treatment of chronic low back pain caused by disc degeneration (CLBP). Its product candidate MPC-150-IM for the treatment or prevention of chronic heart failure and MPC-25-IC for the treatment or prevention of acute myocardial infarction. Its product candidate also includes MPC-300-IV for the treatment of biologic-refractory rheumatoid arthritis and diabetic nephropathy.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellStrong Sell
Technical IndicatorsSellSellBuySellStrong Sell
SummarySellSellNeutralSellStrong Sell
  • SurgeCenter taking a $110M state in MESO. This is going to go gang busters.
    1
    • There's a reddit Mesoblast group at you know the address r/Mesoblast/
      0
      • Wouldn't be lovely to see the shorters get creamed on here and over at the ASX on MSB.ASX
        0
        • I'm from Europe and need some tips on some nice case in US market! Any suggestions guys? I any give you one of my own tips and it's going to give some good % in the nearest future. A great company with the name Africa Energy and exist on CAN and Stockholm market. Thank me later :)
          0
          • LP @8.40
            0
            • George Asp I'm European too, which type of tips do you need? :)
              0
            • Roberto Tacconelli I'm from Sweden! If you have something which is a good deal. I can tell you one that i'm really heavily invested in, its called Africa Energy. Very good potential. They have found one off the biggest oil in Africa. Thank me later :)
              0
            • George Asp Considering the huge offer/demand divergence I don't think investing in a oil company, new or old, is a good idea. Things can go crazy quickly and most of the companies relying only on oil are near bankruptcy. Anyway, as tip, could be a good idea to hard short Moderna once vaccine is approved by FDA. Will follow probably the same Pfizer pattern
              0
          • Picked up a parcel of this fall.
            0
            • James Zheng yes it's a good idea, same experience with SLS for me, not far from it lol
              0
            • Roberto Tacconelli Aussie markekts closed in 36% lower than previous closing day. I guess US market could be the same. Next Monday could keep falling if no news. Most likely. I assumed.
              0
            • James Zheng possible but anything is a bet with this volatility. My advice is just buy the dip or when RSI is high short the retracement
              0
          • Well we're all crying. FDA look after American companies. Good on them. But if you're from another country it going to be a hard road to travel.
            0
            • Now in a Trading Halt. The story just got really exciting. Will we be happy or sad Friday?
              0
              • why is it falling?
                0
                • why is it falling?
                  0